Saraçaydin A, Katircioglu S, Katircioglu S, Karatay M C
Department of Otorhinolaryngology, Istanbul University Faculty School of Medicine, Turkey.
J Int Med Res. 1993 Jul-Aug;21(4):192-6. doi: 10.1177/030006059302100404.
A total of twelve patients with a relatively uncommon form of progressive sensorineural deafness (autoimmune inner-ear disease) were treated orally with 1 mg/kg azathioprine, once daily, and with 30 mg prednisolone, every other day, for 4 weeks. Statistically significant increases in the ability to hear pure tones or in discrimination on audiometry took place in 10/12 patients. This condition was initially described as 'sensorineural hearing loss', but it is now clear that the term 'autoimmune inner-ear disease' is more appropriate since the vestibular compartment as well as the cochlear compartment is involved. This relatively uncommon disease is one of the few forms of sensorineural deafness that can be successfully treated.
共有12例患有相对罕见的进行性感音神经性耳聋(自身免疫性内耳疾病)的患者接受了治疗,口服硫唑嘌呤,剂量为1毫克/千克,每日一次,同时口服泼尼松龙,剂量为30毫克,隔日一次,持续4周。12例患者中有10例在纯音听力或听力测定辨别能力方面出现了具有统计学意义的提高。这种病症最初被描述为“感音神经性听力损失”,但现在很清楚,“自身免疫性内耳疾病”这个术语更合适,因为前庭腔和耳蜗腔都受到了影响。这种相对罕见的疾病是少数几种能够成功治疗的感音神经性耳聋形式之一。